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Adherence to pharmacological treatment for hypertension is considered a key factor in guaranteeing 
successful therapy outcomes. Knowledge of the disease, its complications, as well as the need for changes 
in lifestyle, call for patient motivation and continuous interactive education. The evidence regarding 
the beneficial effects of changes in life style by hypertensive individuals in reducing the complications 
of the disease, as well as in its prevention are indisputable. However, the challenges posed by patient 
adherence to treatment prescribed by doctors remain. The aim of this study was to assess blood pressure 
levels together with degree of adherence to pharmacological treatment with Enalapril Maleate by means 
of the Morisky-Green Test, in hypertensive patients who were users of a School Pharmacy. Of the 102 
patients interviewed, 65.7% had controlled blood pressure, but only 36.3% indicated total compliance 
with the pharmacological treatment. The Morisky-Green test proved ineffective in associating controlled 
blood pressure levels and positive attitudes toward taking antihypertensive medicines.
Uniterms: Adherence. Hypertension. Health Promotion.
A adesão ao tratamento farmacológico da hipertensão arterial sistêmica é considerada uma das etapas 
essenciais para a garantia do seu sucesso. Para tanto, o conhecimento da doença, suas complicações 
e necessidade de mudanças em relação ao estilo de vida, requer do paciente, além da motivação, a 
educação contínua e de modo compartilhado. A evidência quanto aos efeitos benéficos da mudança do 
estilo de vida pelo portador de hipertensão na redução das complicações desta doença, bem como em 
sua prevenção, já não são mais questionados, porém o desafio continua residindo na adesão do indivíduo 
ao padrão de tratamento prescrito pelo médico. Este estudo teve como objetivo avaliar os níveis de 
pressão arterial, assim como o nível de adesão ao tratamento farmacológico com maleato de enalapril 
de pacientes portadores de hipertensão arterial, usuários de uma Farmácia Escola, através do Teste de 
Morisky e Green. Dos 102 pacientes entrevistados, 65,7% apresentaram níveis pressóricos controlados, 
porém apenas 36,3% indicaram níveis de adesão total à terapêutica farmacológica. O teste de Morisky 
e Green não foi eficiente para relacionar níveis de pressão arterial controlado e atitude positiva frente à 
tomada do medicamento anti-hipertensivo fornecido.
Unitermos: Adesão. Hipertensão arterial sistêmica. Promoção da saúde.
INTRODUCTION
The change in mortality profile by groups of causes 
of death as a consequence of the epidemiological tran-
sition has led to the emergence of chronic-degenerative 
diseases as the leading cause of morbidity and mortality 
globally, in both developed and developing countries 
(Omram, 1971). As a result of this phenomenon, a lower 
incidence of infectious-parasitic diseases and an increase 
in neoplastic and cardiovascular disease has been observed 
(Oliveira et al., 2004).
In Brazil, data from 2003 show that 27.4% of de-
aths were attributed to cardiovascular diseases, a figure 
attaining 37% when excluding deaths of ambiguous or 
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violent causes. The leading cause of death throughout the 
Brazilian territory is stroke, occurring more predominantly 
in women (Lotufo, 2005). In addition, these diseases were 
the leading cause of hospitalization in the public sector, 
accounting for 17% of hospital admissions to state hospi-
tals between 1996 and 1999 among patients aged between 
40 and 59 years, and for 29% of patients aged 60 years or 
older (Passos, Assis, Barreto, 2006).
Current trends show a rise in the elderly population 
and increasing longevity, coupled with changes in eating 
habits and lifestyles. A repercussion of an aging population 
is a higher prevalence of chronic diseases such as hyper-
tension (Monego, Jardim, 2006; Passos, Assis, Barreto, 
2006; Lieberman, 2007).
High blood pressure represents a linear and continu-
ous independent risk factor for cardiovascular disease be-
cause it results in complications including cerebrovascular 
disease, coronary artery disease, heart failure, chronic 
renal insufficiency and vascular diseases of the extremities 
(Lewington et al., 2003). Systemic arterial hypertension 
is responsible for 40% of deaths by stroke and 25% by 
coronary heart diseases. The prevalence of hypertension 
ranges between 15% and 20% among the adult population 
and is characterized by high blood pressure (Passos, Assis, 
Barreto, 2006).
According to the V Guidelines on Arterial Hyper-
tension (2007), patients are considered hypertensive if 
they have blood pressure greater than 140 and 90mmHg 
in terms of systolic and diastolic pressures, respectively. 
Controlled patients are individuals whose blood pressure 
is below the levels cited above. Individual characteris-
tics comprise presence of risk factors such as age, high 
cholesterol levels, smoking, diabetes, hereditary factors, 
obesity, sedentary lifestyle and lack of physical exercise, 
stress, consumption of alcoholic beverages, quality of life 
among others.
Hypertension is managed through continuous use 
of medications, changes in life habits and regular visits 
to health services. Non-medicinal approaches such as 
reducing weight, salt intake, alcohol or tobacco use, and 
regular practice of physical activities contribute toward 
controlling pressure levels (Fuchs, Castro, Fuchs, 2004; 
V Brazilian Guidelines on Arterial Hypertension, 2007). 
Treatment using medications is adopted when these mea-
sures are no longer able to control blood pressure.
However, adherence to prescribed courses of medi-
cations and to non-medicinal treatment, which should be 
prescribed and monitored by a multi-disciplinary team 
of health professionals during a visit by the patient to the 
health service, is complex since it involves cultural and 
socioeconomic aspects and often results in continued or 
definitive non-compliance with treatment. Studies have 
shown that rates of abandonment of antihypertensive 
treatment are high, ranging from 15% to 50% within the 
first year of treatment (Giorgio, 2006; Martino et al., 2008; 
Vrjens et al., 2008). Despite efforts to diagnose and treat 
arterial hypertension, between 75% and 92% of those 
undergoing treatment are unable to control blood pressure 
(Stein et al., 2000; Jo et al., 2001; Gu et al., 2002).
Therefore, the role of a multi-disciplined team of 
health professionals is important to help promote adher-
ence to drug treatment in patients with poor blood pres-
sure control. Encouraging the patient to adhere to the 
therapeutic schemes prescribed requires investment by the 
multiprofessional team of dedication, patience and time 
to provide the right information and guidance for patient 
treatment (Giorgio, 2006). 
 According to Giorgio (2006), ensuring adherence to 
treatment requires that “the patient must be aware of their 
state of health, the importance of controlling blood pres-
sure, and of having access to health services, while these 
services must be able to provide treatment throughout the 
life of the patient”.
Poor adherence to treatment is also recognized as an 
economic problem because chronic diseases which are not 
properly treated generate higher costs for the public health 
system (Lessa, 2006).
The role of multidisciplinary healthcare teams, cente-
red on education as a strategy for promoting health, is aimed 
at integral care of the patient as well as identifying circu-
mstances which may hamper adherence of hypertensive 
patients to the indicated treatment. This approach constitutes 
a means of instilling motivation in patients to overcome the 
challenges and adopt attitudes toward improving their well 
being (Fuchs, Castro, Fuchs, 2004; Giorgio, 2006).
Against this background, this study sought to me-
asure blood pressure levels in hypertensive patients who 
were users of a School Pharmacy, and to assess correlation 
with level of adherence to pharmacological treatment with 
Enalapril Maleate by means of the Morisky-Green Test.
MATERIAL AND METHODS
This was a transverse, descriptive, observational 
study with a quantitative approach (Gil, 2010). The study 
sample comprised hypertensive patients who were users 
of the School Pharmacy of the Municipal University of 
São Caetano do Sul (USCS), and recruited as volunteers 
from among those attended at the service. The School 
Pharmacy is part of the Center for Production, Control 
and Dispensing of Medicines (CPCDM) associated with 
the Pharmacy Course of the Municipal University of São 
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Caetano do Sul, in partnership with São Caetano do Sul 
Board of Health. The objective of the service is to cater for 
the needs of the municipal population through the provi-
sion of medicines formulated free of charge in accordance 
with the medical prescription.
Prior to collecting blood pressure measurements for 
the study, upper limbs of each individual were checked 
using the auscultation and aneroid sphygmomanometry 
technique, duly calibrated to rule out divergent values in 
blood pressure between the two upper limbs and to deter-
mine which limb was to be used for measurements throu-
ghout the study. The concept for hypertension described 
in the V Guidelines on Arterial Hypertension (2007) was 
adopted, defining hypertension as systolic blood pressure 
levels (SBP) of greater than or equal to 140 mmHg or dias-
tolic pressure (DBP) of greater than or equal to 90mmHg 
on at least two assessments, with an interval of at least two 
minutes between them. Individuals previously diagnosed 
with hypertension were considered to have controlled 
hypertension when presenting an arithmetic mean of two 
or three blood pressure readings in the upper limb taken in 
the sitting position, with an interval of five minutes betwe-
en measurements, of lower than 140 mmHg for SBP and 
90 mmHg for DBP. Individuals were deemed uncontrolled 
hypertensives when presenting mean pressure levels of 
greater than or equal to 140 mmHg for SBP and 90 mmHg 
for DBP. Patients considered uncontrolled hypertensives 
were classified as hypertension level 1, 2 or 3, or as having 
isolated systolic hypertension 
Assessment of adherence to drug treatment was 
performed based on application of the criteria proposed 
by Morisky and Green (1986). This classification takes 
into account the following items: going without taking 
medication for some reason, i.e. includes abidance to the 
number of medicines and number of doses taken per day; 
2) attitude to not going without medicine, representing 
degree of responsibility and commitment to the treatment; 
3) frequency of forgetting, corresponding to the number of 
occasions the time to take medication was forgotten and 
reveals the degree of commitment to the treatment, but is 
subject to memory labilility and changes in routine which 
may contribute to forgetfulness, 4) attitude to forgetting 
to take the medication, representing the degree of com-
mitment with the treatment, considering the possibility 
of remedying a mistake made. For each criteria, positive 
scores are assigned: (1) if a positive attitude by patient is 
identified, or no score (0), if patient attitude was negative. 
Patients were divided into three groups based on the re-
sults of the analysis of the four criteria: 1) total adherence 
(four points), 2) partial adherence (two or three points) 
and 3) no adherence (one or zero points) (Morisky, Green, 
Levine, 1986).
The following inclusion criteria were adopted: ha-
ving hypertension, with diagnosis confirmed according 
to the clinical criteria proposed by the V Guidelines on 
Arterial Hypertension (2007); be aged 18 year or older; 
be registered at the USCS School Pharmacy for monthly 
collection of medicine for at least three months; in use of 
Enalapril Maleate; users agreeing to participate in the stu-
dy in accordance with the provision in Resolution 196/96 
of the National Medical Council (CNS) (1996). Exclusion 
criteria were: users diagnosed with hypertension younger 
than 18 years of age; not in use of Enalapril Maleate; wo-
men with specific pregnancy-related hypertensive disease, 
users with chronic, degenerative, debilitating diseases or 
neurological sequelae or mental disturbances who present 
limited autonomy and decision-making faculties; and users 
who did not agree to take part or that dropped out of the 
study at any point during the research process. The study 
was conducted between February and June 2008. 
The entire research process was conducted in accor-
dance with the ethical principles set forth in Resolution no. 
196/96 by the National Medical Council of the Ministry 
of Health, guaranteeing participants free and informed 
consent, confidentiality of information and privacy. The 
study protocol was previously approved by the Research 
Ethics Committee of Santa Cecilia University - UNISAN-
TA under process no. 55/07. 
In addition the questionnaire on adherence to drug 
treatment, patients were submitted to a structured ques-
tionnaire on socioeconomic aspects (age, marital status, 
schooling), time since hypertension diagnosis, habits re-
garding tobacco and alcohol use and practice of physical 
activity. The whole process was pretested by applying it 
to ten hypertensive users and adapting as needed.
Statistical Analysis
The data collected was transcribed to an electronic 
form using the statistical software Statistical Package for 
the Social Sciences (SPSS for Windows, version 16.0). 
After data entry to a spreadsheet, exploratory analysis was 
performed to identify the variables and correct any errors 
and/or inconsistencies in data collection and entry. Data 
analysis entailed description of frequencies and perfor-
ming of tests of association for the variables: blood pressu-
re classification, schooling, time in treatment and level of 
adherence (Chi-squared test). Continuous variables were 
expressed as mean and standard deviation and compared 
using Student’s t test. Finally, correlations between level of 
adherence to drug treatment and blood pressure were as-
certained by applying Spearman’s correlation coefficient. 
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A level of 0.05 (or 5%) was considered for rejection of the 
null hypothesis (Hair et al., 2005; Pestana, Gageiro, 2000).
RESULTS
A total of 110 users of the School Pharmacy with 
arterial hypertension were interviewed. Eight individuals 
were excluded from the sample because they had not pro-
vided all the information required. Thus, the final sample 
comprised 102 individuals (53 men and 49 women) with 
a mean age of 67.1 years, 22.5% in the 51 to 60 year age 
bracket and 71.6% aged older than 61 years (Table I). 
Mean disease treatment time was 5.8 ± 5.7 years 
(minimum of three months according to inclusion criteria 
and maximum of 30 years). A total of 17.6% of interview-
ees were undergoing treatment for arterial hypertension for 
at least 1year, 26.5% and 55% had been receiving treat-
ment from 1 to 3 years and more than three years, respec-
tively. Of the patients with controlled and uncontrolled 
blood pressure levels, 36.3% and 22.5% received Enalapril 
Maleate, respectively as the sole medication for control-
ling arterial hypertension. In addition to Enalapril, 16.6% 
also received a diuretic (cloran, hydrochlorothiazide, 
furosemide, chlorthalidone, moduretic) whereas 11.8%, 
together with Enalapril, received another antihypertensive 
(athenolol, carvelidol, captopril or losartan) and 10.8% 
received, in addition to Enalapril, both a diuretic and 
another antihypertensive). A total of 54.9% of interview-
ees had a low level of schooling, i.e. had not completed 
Elementary School, and 68.6% of respondents were mar-
ried. Mean systolic pressure was 120.2 ± 8.7mmHg and 
136.0 ± 15.3mmHg among individuals with controlled 
and uncontrolled arterial pressure, respectively (p ≤ 0.05). 
Levels of diastolic pressure were 76.9 ± 7.2mmHg and 
88.6 ± 6.1mmHg for controlled and uncontrolled cases, 
respectively (p ≤ 0.05). Of patients with controlled arterial 
pressure, 36.3% had total adherence and 29.4% partial 
adherence. Among uncontrolled patients, 12.7% had 
total adherence and 21.6% partial adherence, i.e., 51% of 
patients were considered non-adherents (score ≤ 3). None 
of the patients interviewed reported zero adherence. No 
significant correlation was found between level of adher-
ence and the independent variables.
With regard to the Morisky-Green test (Table II), 
significant correlation was seen only for the item “did not 
forget to take the medicine” (p ≤ 0.05). However, patients 
were found to have a positive attitude toward taking Enala-
pril Maleate, since 91.2% stated that they “did not stop 
taking the medicine when feeling well” and 94.1% “did not 
stop taking it when not feeling well”. The Morisky-Green 
test had sensitivity of 55.2%, specificity of 37.1%, and 
accuracy of 49.0%, indicating that it was ineffective for 
associating arterial pressure control and positive attitude 
toward taking Enalapril Maleate.
DISCUSSION
In the present study, 65.7% of patients submitted 
to treatment with Enalapril Maleate, either as the sole 
medication for controlling arterial hypertension, or in a 
combined dose with diuretics and/or another antihyper-
tensive, had controlled blood pressure levels, but only 
49% of interviewees reported total adherence to treatment. 
Previous studies using the Morisky-Green Test have iden-
tified adherence levels varying from 13.3% (DOSSE et al., 
2010), 23% (Strelec, Pierin, Mion, 2003), 48% (Martino 
et al., 2008), 56% (Bovet et al., 2002), to 76.8% (Pérez 
et al., 2000). However, the results of this last author were 
compared with pill count as opposed to blood pressure 
control. With regard to correlation between adherence 
to the pharmacological therapy and control of blood 
pressure, a significant difference was found only for the 
question “forgot to take the medicine”. Khalil, Elzubier 
(1997) and Bovet et al (2002) described a positive corre-
lation while Strelec, Pierin, Mion (2003) and Wetzels et 
al (2004) found no significant correlation. According to 
Bovet (2002), the method of assessing the criteria adapted 
by the Morisky-Green test is extremely rigorous, given 
that it allows no manner of carelessness or forgetfulness 
regarding time to take the medications. However, isolated 
episodes of forgetting up to once per week are similar to 
daily use, resulting in a lowering of blood pressures over 
a twelve-month period. 
Another aspect to be considered is the capability 
of the Morisky-Green Test to detect patients with con-
trolled pressure that adhere to the treatment. In this study 
the sensitivity of the test was 55.2%. The specificity for 
identifying non-adherent patients with uncontrolled blood 
pressure was 37.1%. Accuracy of the test was 49.0%. 
Strelec, Pierin, Mion (2003) found specificity of 70%, low 
sensitivity (39%) and low accuracy (39%). Thus, akin to 
the findings of Strelec, Pierin, Mion (2003) the present 
study found the Morisky-Green test to be ineffective in 
associating arterial pressure control and level of adherence 
to pharmacological treatment.
The fact that patients were dispensed medications 
free of charge from the School Pharmacy may have had 
a positive influence on levels of total adherence to treat-
ment, since according to the Pedagogic Project of the 
Pharmacy Course of the Municipal University of São 
Caetano do Sul (USCS), there is a concern with training 
students to be humanistic professionals, who are centered 
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TABLE I - Distribution of controlled and uncontrolled hypertensive patients according to sociocultural and disease characteristics.
Controlled 
N = 67
Uncontrolled 
N = 35
Total 
N = 102
Gender N (%) N (%) N (%)
Male 32 (31.4) 21 (20.6) 53 (52.0)
Female 35 (34.3) 14 (13.7) 49 (48.0)
Educational Level
Without schooling 41 (40.2) 15 (14.7) 56 (54.9)
With schooling 26 (25.6) 20 (19.6) 46 (45.1)
Marital Status
Single 04 (3.9) 03 (2.9) 07 (6.9)
Married 49 (48.0) 21 (20.6) 70 (68.6)
Widow/Widower 12 (11.8) 08 (7.8) 20 (19.6)
Separated 02 (2.0) 03 (2.9) 05 (4.9)
Age Group
< 40 years 02 (2.0) 01 (1.0) 03 (2.9)
41 – 50 02 (2.0) 01 (1.0) 03 (2.9)
51 to 60 14 (13.7) 09 (8.8) 23 (22.5)
> 60 years 49 (48.0) 24 (23.5) 73 (71.6)
Time in treatment
< 1 year 10 14.9 08 22.9 18 17.6
1 to 3 years 16 23.9 11 31.4 27 26.5
> 3 years 41 61.2 16 45.7 57 55.9
No. medications prescribed
one 36 (35.3) 22 (21.6) 58 (56.9)
two 18 (17.6) 11 (10.8) 29 (28.4)
≥ three 13 (12.7) 02 (2.0) 15 (14.7)
Medications prescribed for controlling hypertension
Enalapril 37 (36.3) 23 (22.5) 60 (58.8)
Enalapril + diuretic 12 (11.7) 05 (4.9) 17 (16.6)
Enalapril + antihypertensive 07 (6.9) 05 (4.9) 12 (11.8)
Enalapril + diuretic + antihypertensive 11 (10.8) 02 (2.0) 13 (12.8)
Level of Adherence
Total Adherence 37 (36.3) 12 (12.7) 50 (49)
Partial Adherence 30 (29.4) 22 (21.6) 52 (51)
No Adherence - - - - - -
Blood Pressure Levels
Excellent 10 (9.8) - - 10 (9.8)
Normal 33 (32.4) - - 33 (32.4)
Borderline 24 (23.5) - - 24 (23.5)
Hypertension level 1 - - 31 (30.4) 31 (30.4)
Hypertension level 2 - - 03 (2.9) 03 (2.9)
Isolated Hypertension. - - 01 (1.0) 01 (1.0)
Age (years) 67.4 ± 10.6 66.6 ± 11.1 67.1 ± 10.7
No. of medications 3.8 ± 2.3 3.4 ± 1.9 3.7 ± 2.2
Systolic blood pressure* 120.2 ± 8.7 136.0 ± 15.3 125.6 ± 13.6
Diastolic blood pressure* 76.9 ± 7.2 88.6 ± 6.1 80.9 ± 8.8
* p ≤ 0.05
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TABLE II - Distribution of controlled and uncontrolled hypertensives according to the Morisky-Green test
Controlled 
N = 67
Uncontrolled 
N = 35
Total 
N = 102
Sensitivity 
(%)
Specificity 
(%)
Accuracy
(%)
N (%) N (%) N (%)
Forgot to take the medicine?
Yes 21 (20.6) 19 (18.6) 40 (39.2) 69 46 39
No 46* (45.1) 16 (15.7) 62 (60.8)
Despite remembering, did not take the medicine?
Yes 13 (12.7) 04 (3.9) 17 (16.7) 81 89 17
No 54 (52.9) 31 (30.4) 85 (83.3)
Stopped taking the medicine when feeling well?
Yes 06 (5.9) 03 (2.9) 09 (8.8) 91 91 9
No 61 (59.8) 32 (31.4) 93 (91.2)
Stopped taking the medicine when not feeling well?
Yes 04 (3.9) 02 (2.0) 06 (5.9) 67 34 66
No 63 (61.8) 33 (32.4) 96 (94.1)
* p ≤ 0.05
on the patients and not only on the medication. In other 
words, care is taken to develop the practice of Pharmacist 
Attention, which considers the patient as a whole together 
with general and specific needs concerning the medica-
tion. Pharmacist Attention encompasses attitudes, ethical 
values, behaviors, ability and co-responsibility in disease 
prevention, promotion and recovery of health, in an inte-
grated manner with health teams (Jaramillo et al., 2005). 
According to Angonesi (2008), the pharmacist must also 
assume a role of responsibility for the therapy (not merely 
acting as a subordinate to medical authorities) by promot-
ing rational use of medications thus transforming the 
pharmacy into a health establishment. Therefore, training 
and education should be focused on critical practice and 
not in training a simple technician in medications. Pharma-
ceutical activities should be patient oriented, contributing 
to improvements in overall condition of health and use of 
medications by the Brazilian population. 
Nobre, Pierin, Mion (2001) defined adherence to 
therapy as “level of conscience between medical prescrip-
tion and patient behavior”. In this context, the approach of 
hypertensive patients currently requires, besides technical 
knowledge, the perception of the socio-economic and cul-
tural environment of the individual, such that therapeutic 
guidance given is congruent with their reality and achieves 
the treatment objectives. 
According to Araújo and Garcia (2002), the vari-
ables involved in the process of adherence can be split 
into three groups, namely, those related to the patient, the 
therapeutics (costs, undesirable effects, complex treat-
ment schemes and quality of life) and the health system 
(access to the health services, waiting time and length of 
consultation), plus other factors such as time in treatment 
and complications secondary to the disease (Gusmão, 
Mion, 2005; Santos et al., 2005; Araujo, Garcia, 2006). 
Regarding patient-related aspects, variables such as gen-
der, age, educational level, income and marital status must 
be considered. Knowledge, perception and beliefs about 
hypertension, previous experience with the disease in the 
setting in which they live, their desire to learn, how to treat 
the disease and motivation to follow advice, combined 
with family and social support are all important factors to 
be taken into consideration in patient adherence to treat-
ment (Jesus et al., 2008). 
This study revealed that the patients took an aver-
age of 3 different medications per day (minimum 1 and 
maximum 12). According to Rocha et al (2008), the 
number of medications, the complex posology and col-
lateral effects negatively influence the process. When 
prescribing pharmacological treatment, the physician 
should consider the frequency of doses, times of taking 
medicines, efficacy, undesirable adverse effects as well as 
the economic aspect. Whereas for non-pharmacological 
therapy, the ability of the patient to adapt to the new 
lifestyle, including regular practice of physical exercises, 
weight loss, changes in eating habits (i.e. cutting down 
intake of salt, saturated fats and sugars, since hyperten-
sive patients are also dyslipidemic and diabetic), besides 
abandoning smoking and drinking habits (Farinatti et 
al., 2005; Gravina, Grespan, Borges, 2008). In relation 
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to health services, aspects such as access, availability of 
a multi-disciplinary team of healthcare professionals as 
well as medications, frequency of consultations, health 
team-patient relationship, satisfaction of the individual 
with service, including guidance, respect, and joint 
decision-making are deemed pre-requisites to achieving 
satisfactory adherence (Coelho et al., 2005; Qureshi et 
al., 2007; Giorgi, 2008). 
In this study, 58.8% of the patients received Enala-
pril Maleate as the sole medication for controlling arterial 
hypertension, although only 36.3% had controlled blood 
pressure. The remaining patients received two or more 
difference medicines (diuretics and/or other anti-hyper-
tensive) for controlling the disease. According to Ribeiro 
(2005), the use of medication in the management of hyper-
tension is essential, given the multifactorial characteristic 
of arterial hypertension, emphasizing that monotherapy 
using any class of medications only reduces systolic and 
diastolic pressures by 4% and 8% respectively, compared 
to baseline levels. By contrast, patients treated with a 
combination or association of two antihypertensives can 
expect reductions of 8% to 15% in blood pressure levels, 
that is, combining antihypertensive therapies can increase 
the likelihood of achieving better control of pressure and 
improve the 30% to 40% range of normalization under 
monotherapy, to levels of between 70% and 80%.
A highly relevant aspect of hypertension treatment 
is effective pressure control allied with low incidence 
of side effects. In this respect, the use of several agents 
combined in low doses has been increasingly proposed 
because they enable synergic action on different caus-
ative mechanisms of arterial hypertension, without the 
inconvenience of adverse clinical or laboratory effects 
found when using higher doses of single drug (Franco et 
al., 2005). Angiotensin I-converting enzyme inhibitors 
warrant special attention since they are effective, able to 
protect target organs and have a low level of collateral 
effects, with cephalea and cough being the most frequent 
side effects, i.e. they are well tolerated (Milagres, 2005). 
This fact partly explains why 94.1% of patients displayed 
a positive attitude toward using Enalapril. 
Therefore, active participation in the treatment, in-
volving correct use of medications, monitoring treatment 
and attending appointments, as well as changes in life style 
(eating habits, practicing physical activity) are considered 
the attributes underlying the adherence concept (Araujo, 
Garcia, 2006). According to Giorgi (2006), in order to at-
tain adherence to treatment, the patient must understand 
their health condition, the importance of controlling blood 
pressure and of having access to health services, services 
which must be capable of providing continued treatment 
throughout the patient’s life. The poorer the socioeco-
nomic conditions faced by individuals, the greater the 
barriers to them continuing adequate treatment. 
To conclude, important aspects should be observed 
to promote greater adherence to treatment including gen-
der differences, proper analysis of the drug, investigation 
of drug interactions and associated conditions, assessment 
and correction of therapeutic schemes, elimination of rea-
sons for non-control related to the prescriber and patient, 
search for secondary causes, personalizing of patient care, 
auditing of prescriptions to identify non-responsiveness of 
patients to a given drug and, lastly self-monitoring (Castro 
et al., 2006; Bakris et al., 2008; Wen-Wen et al., 2008). 
To this end, the services carried out by pharmacists, par-
ticularly those adopting the Pharmacist Attention concept, 
contribute toward adherence to pharmacological treatment 
(Côté et al., 2005; Castro et al., 2006). 
CONCLUSION
Professional pharmacists, during their training and 
education, should be made aware of the importance of 
their active role in treating chronic diseases encompassing 
the rational use of medications, treatment monitoring and 
identifying ways of promoting improved adherence to 
prescribed treatment and better control of blood pressure.
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